These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 24556216
1. Evaluation of genome-wide loci of iron metabolism in hereditary hemochromatosis identifies PCSK7 as a host risk factor of liver cirrhosis. Stickel F, Buch S, Zoller H, Hultcrantz R, Gallati S, Österreicher C, Finkenstedt A, Stadlmayr A, Aigner E, Sahinbegovic E, Sarrazin C, Schafmayer C, Braun F, Erhart W, Nothnagel M, Lerch MM, Mayerle J, Völzke H, Schaller A, Kratzer W, Boehm BO, Sipos B, D'Amato M, Torkvist L, Stal P, Arlt A, Franke A, Becker T, Krawczak M, Zwerina J, Berg T, Hinrichsen H, Krones E, Dejaco C, Strasser M, Datz C, Hampe J. Hum Mol Genet; 2014 Jul 15; 23(14):3883-90. PubMed ID: 24556216 [Abstract] [Full Text] [Related]
2. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE-related hemochromatosis. Pelucchi S, Galimberti S, Greni F, Rametta R, Mariani R, Pelloni I, Girelli D, Busti F, Ravasi G, Valsecchi MG, Valenti L, Piperno A. J Gastroenterol Hepatol; 2016 Jul 15; 31(7):1342-8. PubMed ID: 26868056 [Abstract] [Full Text] [Related]
3. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis. de Tayrac M, Roth MP, Jouanolle AM, Coppin H, le Gac G, Piperno A, Férec C, Pelucchi S, Scotet V, Bardou-Jacquet E, Ropert M, Bouvet R, Génin E, Mosser J, Deugnier Y. J Hepatol; 2015 Mar 15; 62(3):664-72. PubMed ID: 25457201 [Abstract] [Full Text] [Related]
4. Variants in PCSK7, PNPLA3 and TM6SF2 are risk factors for the development of cirrhosis in hereditary haemochromatosis. Buch S, Sharma A, Ryan E, Datz C, Griffiths WJH, Way M, Buckley TWM, Ryan JD, Stewart S, Wright C, Dongiovanni P, Fracanzani A, Zwerina J, Merle U, Weiss KH, Aigner E, Krones E, Dejaco C, Fischer J, Berg T, Valenti L, Zoller H, McQuillin A, Hampe J, Stickel F, Morgan MY. Aliment Pharmacol Ther; 2021 Apr 15; 53(7):830-843. PubMed ID: 33565643 [Abstract] [Full Text] [Related]
5. Genetic modifiers of penetrance to liver endpoints in HFE hemochromatosis: Associations in a large community cohort. Pilling LC, Atkins JL, Melzer D. Hepatology; 2022 Dec 15; 76(6):1735-1745. PubMed ID: 35567766 [Abstract] [Full Text] [Related]
6. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. Valenti L, Maggioni P, Piperno A, Rametta R, Pelucchi S, Mariani R, Dongiovanni P, Fracanzani AL, Fargion S. World J Gastroenterol; 2012 Jun 14; 18(22):2813-20. PubMed ID: 22719190 [Abstract] [Full Text] [Related]
7. Penetrance of the C28Y/C282Y genotype of the HFE gene. Asberg A, Hveem K, Kannelønning K, Irgens WØ. Scand J Gastroenterol; 2007 Sep 14; 42(9):1073-7. PubMed ID: 17710673 [Abstract] [Full Text] [Related]
8. [Molecular genetic diagnostics and screening of hereditary hemochromatosis]. Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S. Vnitr Lek; 2006 Jun 14; 52(6):602-8. PubMed ID: 16871764 [Abstract] [Full Text] [Related]
9. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes. Cheng R, Barton JC, Morrison ED, Phatak PD, Krawitt EL, Gordon SC, Kowdley KV. J Clin Gastroenterol; 2009 Jul 14; 43(6):569-73. PubMed ID: 19359997 [Abstract] [Full Text] [Related]
10. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, Siewert E, Gartung C, Lorenzen J, Bosserhoff AK, Brügmann M, Gressner AM, Matern S, Lammert F. Liver Int; 2004 Aug 14; 24(4):285-94. PubMed ID: 15287851 [Abstract] [Full Text] [Related]
11. Iron-overload-related disease in HFE hereditary hemochromatosis. Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. N Engl J Med; 2008 Jan 17; 358(3):221-30. PubMed ID: 18199861 [Abstract] [Full Text] [Related]
12. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. Press RD, Flora K, Gross C, Rabkin JM, Corless CL. Am J Clin Pathol; 1998 May 17; 109(5):577-84. PubMed ID: 9576576 [Abstract] [Full Text] [Related]
17. Iron loading and morbidity among relatives of HFE C282Y homozygotes identified either by population genetic testing or presenting as patients. McCune CA, Ravine D, Carter K, Jackson HA, Hutton D, Hedderich J, Krawczak M, Worwood M. Gut; 2006 Apr 17; 55(4):554-62. PubMed ID: 16174659 [Abstract] [Full Text] [Related]
18. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Allen KJ, Bertalli NA, Osborne NJ, Constantine CC, Delatycki MB, Nisselle AE, Nicoll AJ, Gertig DM, McLaren CE, Giles GG, Hopper JL, Anderson GJ, Olynyk JK, Powell LW, Gurrin LC, HealthIron Study Investigators. Hepatology; 2010 Sep 17; 52(3):925-33. PubMed ID: 20583211 [Abstract] [Full Text] [Related]
19. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population. Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD. Isr Med Assoc J; 2004 Jan 17; 6(1):30-3. PubMed ID: 14740507 [Abstract] [Full Text] [Related]
20. Could iron deposits in hepatocytes serve as a prognostic marker of HFE gene mutations? Sikorska K, Stalke P, Jaskiewicz K, Romanowski T, Bielawski KP. Hepatogastroenterology; 2008 Jan 17; 55(84):1024-8. PubMed ID: 18705322 [Abstract] [Full Text] [Related] Page: [Next] [New Search]